| Structure |
Chemical Name |
CAS |
MF |
 |
MG-132 |
133407-82-6 |
C26H41N3O5 |
 |
Carfilzomib |
868540-17-4 |
C40H57N5O7 |
 |
DAPT |
208255-80-5 |
C23H26F2N2O4 |
![2-Naphthacencarboxamid, 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Monohydrochlorid, [4S-(4α,4aα,5α,5aα,6α,12aα)]-](/CAS/GIF/10592-13-9.gif) |
2-Naphthacencarboxamid, 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Monohydrochlorid, [4S-(4α,4aα,5α,5aα,6α,12aα)]- |
10592-13-9 |
C22H25ClN2O8 |
 |
Telaprevir |
402957-28-2 |
C36H53N7O6 |
 |
ALOGLIPTIN(ALOGLIPTINE, ALOGLIPTINA) |
850649-61-5 |
C18H21N5O2 |
 |
Nelfinavir mesylate |
159989-65-8 |
C33H49N3O7S2 |
 |
Nafamostat mesylate |
82956-11-4 |
C21H25N5O8S2 |
 |
Omarigliptin (MK-3102) |
1226781-44-7 |
C17H20F2N4O3S |
 |
Ledipasvir |
1256388-51-8 |
C49H54F2N8O6 |
 |
Daclatasvir |
1009119-64-5 |
C40H50N8O6 |
 |
Semagacestat |
425386-60-3 |
C19H27N3O4 |
 |
EST |
88321-09-9 |
C17H30N2O5 |
 |
Calpain Inhibitor I |
110044-82-1 |
C20H37N3O4 |
 |
MK-0822 |
603139-19-1 |
C25H27F4N3O3S |
 |
CALPEPTIN |
117591-20-5 |
C20H30N2O4 |
 |
CEP-18770 |
847499-27-8 |
C21H28BN3O5 |
 |
(R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid |
1072833-77-2 |
C14H19BCl2N2O4 |
 |
Danoprevir |
850876-88-9 |
C35H46FN5O9S |
![cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid](/CAS/GIF/471905-41-6.gif) |
cis-4-[(4-Chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexanepropanoic acid |
471905-41-6 |
C21H21ClF2O4S |
 |
AZD 9668 |
848141-11-7 |
C25H22F3N5O4S |
 |
Ilomastat |
142880-36-2 |
C20H28N4O4 |
 |
DIBENZAZEPINE |
209984-56-5 |
C26H23F2N3O3 |
 |
RO4929097 |
847925-91-1 |
C22H20F5N3O3 |
 |
Teneligliptin Hydrobromide |
906093-29-6 |
C22H31BrN6OS |
 |
Batimastat |
130370-60-4 |
C23H31N3O4S2 |
 |
LY411575 |
209984-57-6 |
C26H23F2N3O4 |
 |
ONX-0914 |
960374-59-8 |
C31H40N4O7 |
 |
Cathepsin Inhibitor 1 |
225120-65-0 |
C20H24ClN5O2 |
 |
PD 151746 |
179461-52-0 |
C11H8FNO2S |
 |
Marimastat |
154039-60-8 |
C15H29N3O5 |
 |
Avagacestat (BMS-708163) |
1146699-66-2 |
C20H17ClF4N4O4S |
 |
Darunavir ethanolate |
635728-49-3 |
C29H43N3O8S |
 |
PI-1840 |
1401223-22-0 |
C22H26N4O3 |
 |
E-64C |
76684-89-4 |
C15H26N2O5 |
 |
VX-222 |
1026785-59-0 |
C25H35NO4S |
 |
Oprozomib |
935888-69-0 |
C25H32N4O7S |
 |
Trelagliptin |
865759-25-7 |
C18H20FN5O2 |
 |
MLN9708 |
1201902-80-8 |
C20H23BCl2N2O9 |
 |
3,4-Dichloro-N-(1-Methylbutyl)benza-Mide |
7497-07-6 |
C12H15Cl2NO |
 |
FLI-06 |
313967-18-9 |
C25H30N2O5 |
 |
MMP-2/MMP-9 INHIBITOR IV |
292605-14-2 |
C15H14O3S2 |
 |
Z-PHE-DL-ALA-FLUOROMETHYLKETONE |
197855-65-5 |
C21H23FN2O4 |